Abstract

The new information flows and the collapse of the journalistic monopoly in the intermediation with the public, have created opportunities and dysfunctions in biomedical information. To the problems of hype and commercialization, those related to the lack of filters and the diffusion of bad science have been added. This article discusses the challenges posed by these problems and the perspectives in academic research, communication and journalism.